SANGAMO THERAPEUTICS INC (SGMO) Stock Cash Flow
NASDAQ:SGMO - Nasdaq - US8006771062 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -79.45M | -97.94M | -257.83M | -192.30M | -178.30M | |||
| Depreciation Amortization | 4.72M | 5.11M | 15.06M | 12.10M | 9.40M | |||
| Income Taxes - Deferred | N/A | 0.00 | -6.33M | N/A | N/A | |||
| Change In Working Capital | 13.32M | 4.51M | -164.03M | -82.30M | -101.90M | |||
| Other non cash items | 16.76M | 21.19M | 188.29M | 38.90M | 37.50M | |||
| OPERATING CASH FLOW | -44.63M | -67.14M | -224.84M | -223.60M | -233.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -267.00K | -21.16M | -20.20M | -23.30M | |||
| Other Investing Activity | 1.95M | 37.79M | 174.69M | 79.50M | 271.50M | |||
| INVESTING CASH FLOW | 1.68M | 37.52M | 153.53M | 59.30M | 248.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 17.12M | 29.28M | 16.04M | 86.80M | 36.10M | |||
| Other Financing Activity | -2.73M | -904.00K | -1.45M | -2.10M | -3.30M | |||
| FINANCING CASH FLOW | 14.39M | 28.38M | 14.59M | 84.70M | 32.90M | |||
| Exchange Rate Effect | -101.00K | -2.05M | 1.48M | 1.30M | -300.00K | |||
| CHANGE IN CASH | -28.65M | -3.29M | -55.24M | -78.30M | 47.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -44.63M | -67.14M | -224.84M | -223.60M | -233.30M | |||
| Capital Expenditure | N/A | -267.00K | -21.16M | -20.20M | -23.30M | |||
| FREE CASH FLOW | -44.89M | -67.41M | -246.00M | -243.80M | -256.60M | |||
All data in USD